Journey Medical Corporation

DERM | NASDAQ

Price Alert Chart Builder DCF Calculator

$7.25

+$0.26 (+3.72%)

At close: Sep 22, 2026, 4:00 PM ET

$7.25

$0 (0.00%)

After-hours: Sep 22, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+3.72%

(1D)

Rating

Updated: Aug 31, 2026

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $199.53M

1D Range

7.02 7.39

52W Range

4.31 9.56

Valuation (TTM)

PE -30.39

PB 5.99

EV/EBITDA 103.99

Valuation (NTM)

Forward PE 11.66

Forward PEG 0.02

Price Target $11.75

Cash Flow

FCF Yield -3.9%

SBC Adj. FCF Yield -7.0%

SBC Impact -80.8%

Margins

Gross Margin 62.2%

Operating Margin -4.4%

FCF Margin -11.0%

Growth (CAGR)

Revenue 3Y | 5Y 3.5% | 6.8%

Dil EPS 3Y | 5Y -52.4% | 64.9%

FCF 3Y | 5Y 3.9% | 34.2%

Returns

ROA -6.2%

ROE -20.2%

ROIC -5.2%

Financial Health

Net Cash

$102K

Current Ratio 1.59

Interest Coverage -0.82

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Journey Medical Corporation, a pharmaceutical firm established in Scottsdale, Arizona in 2014 (and previously known as Coronado Dermatology, Inc.), is dedicated to the development and market introduct...

Sector Healthcare

Industry Drug Manufacturers - Specialty & Generic

Employees 58

IPO Date Nov 11, 2021

Website journeymedicalcorp.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 11, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

$11.75

Upside

+62.07%

Buy (2)

Hold (0)

Sell (0)

Analyst Details ➞